Journal article
Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review and meta-analysis
Abstract
BackgroundChronic kidney disease-mineral and bone disorders (CKD-MBD) have been associated with poor health outcomes, including diminished quality and length of life. Standard management for CKD-MBD includes phosphate-restricted diet, active vitamin D, vitamin D analogs, and phosphate binders. Persistently elevated parathyroid hormone (PTH) levels may require the addition of Cinacalcet hydrochloride (cinacalcet) which sensitizes calcium …
Authors
Sekercioglu N; Busse JW; Mustafa RA; Guyatt GH; Thabane L
Journal
Systematic Reviews, Vol. 5, No. 1,
Publisher
Springer Nature
Publication Date
12 2016
DOI
10.1186/s13643-015-0177-1
ISSN
2046-4053